局部用雷帕霉素聚乳酸乙醇酸共聚物缓释微球制备及释药探究.docVIP

局部用雷帕霉素聚乳酸乙醇酸共聚物缓释微球制备及释药探究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
局部用雷帕霉素聚乳酸乙醇酸共聚物缓释微球制备及释药探究

局部用雷帕霉素聚乳酸乙醇酸共聚物缓释微球制备及释药探究[摘要]目的:介绍雷帕霉素(RAPA)聚乳酸乙醇酸共聚物(PLGA)缓释微球的制备方法,建立高效液相色谱法(HPLC)测定体系以检测微球中雷帕霉素含量,检测微球性状并进行体外释药实验。方法:以聚乳酸乙醇酸共聚物为载体,采用W/O/W 乳剂-扩散溶剂挥发法制备雷帕霉素缓释微球,扫描电镜检测微球外观及微球粒径,HPLC检测微球载药量、包封率及体外释药量。结果:所制微球光滑圆整,大小均一,平均粒径:(121.18±27.83)μm,载药率:(14.39 ± 1.32)%,包封率:(72.92±4.29)%,体外释放实验显示1~4天有突释,随后平稳释药至第10天累积释药率达80%。结论:采用制备工艺稳定,所制微球载药量及包封率均较高,形态完整,大小均一,体外释药较为平稳并且具有明显的缓释作用。 [关键词]雷帕霉素;缓释;微球;PLGA [中图分类号]Q813.1[文献标识码]A[文章编号]1008-6455(2010)03-0334-04 Preparation and in vitro release study of rapamycin in poly(lactic-co-glycolic )acid microsphere for topical administration PEI Jiao-miao,XUE Xiao-yan,LIU Bei,XIA Wei,LUO Xiao-xing,GUO Shu-zhong (Institute of Plastic Surgery of People’s Liberation Army,Xijing Hospitol,the Fourth Military Medical University,Xi’an 710032,Shaanxi,China) Abstract:ObjectiveTo optimize the preparation technology of poly (lactide - co - glycolide) (PLGA) microspheres loaded with rapamycin (RAPA-PLGA-MS), establish a HPLC method for content determination of rapamycin in microspheres and study powder particle characteristics and in vitro release characteristics of RAPA-PLGA-MS. Methods RAPA-PLGA-MS was prepared with PLGA as carriers by the water-in-oil-in-water(W/O/W) emulsion solvent evaporation method. Scanning electron miroscope (SEM) and HPLC were used to evaluate the micromeritic characteristics of RAPA-PLGA-MS, such as the particle size,loading efficiency, and entrapment efficiency and in vitro release characteristics.ResultsThe prepared microspheres were spherical with smooth surfaces,with an average particle size of (121.18±27.83) μm. The loading and encapsulation efficiency were (14.39±1.32)% and (72.92±4.29)% respectively. The in vitro release curve of RAPA-PLGA-MS was up to 80% in 10 days.Conclusions Rapamycin poly(lactic-co-glycolic )acid microspheres was successfully prepared and has obvious sustained release. Key words:rapamycin;controlled release;microspheres;PLGA 随着显微外科技术的进步与推广以及抗免疫排斥药物的研发与改良,同种异体复合组织移植在整形外科领域的应

文档评论(0)

docman126 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:7042123103000003

1亿VIP精品文档

相关文档